Search results
Ozempic weight loss guide: Benefits and side effects
The Telegraph via Yahoo News· 3 days agoIt seems as though Ozempic and other weight-loss jabs are everywhere – and the appetite for them shows no signs of slowing down - with the industry...
What Doctors Want You to Know About ‘Ozempic Breasts’
Prevention via Yahoo News· 2 days agoSome taking Ozempic and Wegovy are seeing changes in the size and shape of their breasts, calling...
Collaboration Tackles Steroid-Induced Adrenal Insufficiency
Medscape· 17 hours agoPublication of the guidance marks the first time that the European Society of Endocrinology (ESE)...
Women who start menopause before this age more likely to die young
Alaska Superstation· 3 days agoWomen who enter menopause before the age of 40 are more likely to die young, suggests new research....
Olivia Munn and John Mulaney froze embryos in hopes of having another baby after her breast cancer...
Yahoo Life· 8 hours ago“It is extremely common for reproductive endocrinologists to work together with oncologists and...
Q&A: Researcher discusses changing the pregnancy culture to 'eating for you,' not for two
Medical Xpress· 2 hours ago"Pregnancy is a unique event that influences the future health of both mothers and babies," said...
Most slow responders to tirzepatide do lose clinically meaningful weight
Medical Xpress· 1 day agoAmong slow responders to tirzepatide treatment at week 12, 90 percent went on to achieve clinically...
Pregnancy stress can lower IQ of boys before they’re even born, new study warns
NY Post via Yahoo News· 3 days agoThe findings are due to be presented at the 26th annual European Congress of Endocrinology in...
The pros and cons of weight-loss drugs
The Telegraph via Yahoo News· 2 days agoThe new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that regulates insulin levels and...
Neurocrine shares new CAH treatment data at endocrinology congress By Investing.com
Investing.com· 2 days agoThe company presented baseline characteristics from the CAHtalyst™ Phase 3 trials of crinecerfont in...